Proud to be an Indiblogger

Friday, March 30, 2018

little blue pill



20 years back Pfizer the multinational pharmaceuticals hit a jackpot
Serendipity selects its rewards with no criterions but pure luck.
The chemical molecule called Sildenafil citrate was one of the several research molecules in the pipeline for Pfizer.
Millions of dollars are spent on three or more phases of meticulous laborious long clinical trials of several molecules by these companies with deep long pockets and one in say ten could
 be accepted one in hundred can make profit but only one in a million should hit the jackpot .
Sildenafil was more intended for pulmonary hypertension chronic lung and cardiac failures as it dilated blood vessels increasing vascularity and oxygenation and better cardiac output.
Now dilatation of blood vessels in male sexual organ produces erection and this was a side effect only but then this was something desired by the male population for aeons as a fantasy need and also by the female population depressed and dejected by universal flaccidity.
All the mumbo jumbo herbs ,amulets ,mantras ,grandmas cures concocted, conning medicines made more money to its makers instead of raising the spirits and organs of the men who swallowed them 
And then comes this short sweet potent dynamite raising dead objects in perfect salutes 
Suddenly Pfizer knew it was going to shake the world nay raise the worlds nether masculine regions and thus bring in zillions of dollars .
The little blue tablet Viagra became just that.
Urologist’s pulmonologists who generally prescribed them became as popular as film stars 
After all it was non biblical resurrection of faded hopes.
Actually India brought a slew of over counter ones with names like
Cadevra 
this was a misnomer as cant associate erection to cadavers can we ?
Maybe they meant even raise the dead’s .
And thus two decades has passed since countless homes had bouncing beds
Invigorated spirits maybe thousands of toddlers populated the earth due to those pills
God himself should have wondered if Pfizer was competition

No comments:

Powered By Blogger

Blog Archive